A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 22, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

July 3, 2020

Conditions
Sedation
Interventions
DRUG

HSK3486 0.1-0.2 /0.3 mg / kg group

Administered with HSK3486 at a loading dose of 0.1-0.2 mg/kg via intravenous pump. Then HSK3486 shall be administered immediately at an initial maintenance dose of 0.3 mg/kg/h respectively.

DRUG

Propofol 0.5-1.0/1.5 mg/kg group

Administered with Propofol at a loading dose of 0.5-1.0mg/kg via intravenous pump. Then Propofol shall be administered immediately at an initial maintenance dose of 1.5 mg/kg/h respectively.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Sun Yat-sen University, Guanzhou

All Listed Sponsors
lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT04147416 - A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation | Biotech Hunter | Biotech Hunter